about
Introduction to radiobiology of targeted radionuclide therapyRadiobiological restrictions and tolerance doses of repeated single-fraction hdr-irradiation of intersecting small liver volumes for recurrent hepatic metastases.Impact of hypofractionation and tangential beam IMRT on the acute skin reaction in adjuvant breast cancer radiotherapy.A new view of radiation-induced cancer: integrating short- and long-term processes. Part II: second cancer risk estimation.General overview of radioimmunotherapy of solid tumors.The use of equivalent radiation dose in the evaluation of late effects after childhood cancer treatment.Postoperative radiotherapy in DBCG during 30 years. Techniques, indications and clinical radiobiological experience.Radiosensitivity and cell cycle redistribution of cultured human tumour cells during fractionated daily 2-Gy irradiations.A Retrospective Analysis of Toxicity and Efficacy for 2 Hypofractionated Irradiation Schedules Versus a Conventional One for Post-Mastectomy Adjuvant Radiotherapy in Breast Cancer.Application of organ tolerance dose-constraints in clinical studies in radiation oncology.Effect of daily fraction size on laryngoesophageal dysfunction after chemoradiation for squamous cell carcinomas of the larynx and hypopharynx.Impact of dose size in single fraction spatially fractionated (grid) radiotherapy for melanoma.Improving the therapeutic ratio in stereotactic radiosurgery: optimizing treatment protocols based on kinetics of repair of sublethal radiation damage.Radiation fractionation: the search for isoeffect relationships and mechanisms.Optimal fractionation in radiotherapy with multiple normal tissues.The clinical radiobiology of brachytherapy.The alfa and beta of tumours: a review of parameters of the linear-quadratic model, derived from clinical radiotherapy studies.Hypofractionated Adjuvant Whole Breast Radiotherapy: Progress and Prospects
P2860
Q26852029-97B333CA-FE4C-421F-A328-64B8BC387F79Q33922093-FA6F9AF3-6A90-492C-B0F6-693F219B99DEQ37139905-F395849D-D3AE-4E23-85E5-FF859821D7A6Q37272805-03346BE8-7550-494A-875A-27A216F94254Q38103579-5A2D51A2-5952-431B-8EC0-8D058A655806Q39176177-AE2B8BE0-75EF-40AF-8857-9EB02EC93115Q40094272-20AF3703-51AD-4A90-810B-0E946DB6654AQ41390045-C4C1467E-DA8B-4FFB-AF35-790025E3976EQ41635905-C0F9BC64-7419-4804-921E-AC75725E5D0BQ45859764-92D138C2-00DD-43DF-A98E-E3F4A94EBEC2Q46110288-5D7859F1-A6FF-4611-85E7-93A557CCA973Q47184504-9E9B0FDA-15C4-4337-B25A-334241E4965BQ48145212-3856A853-FE2D-4DEE-A349-437C123E22D9Q48261293-FE563D12-4537-4DB8-9298-4BFD59C10050Q50912967-6FCBA6B3-E0E3-4C8F-BC84-EFD5B951E323Q52238425-1E6E367D-2DAE-4D1B-91E4-285D6F526CC2Q55033689-010EF1FA-94FF-4C10-9DE4-3C9D5FEC34CCQ57397738-82BA85DC-2848-4CDD-ACD7-6115F1372AFC
P2860
description
1989 nî lūn-bûn
@nan
1989年の論文
@ja
1989年学术文章
@wuu
1989年学术文章
@zh-cn
1989年学术文章
@zh-hans
1989年学术文章
@zh-my
1989年学术文章
@zh-sg
1989年學術文章
@yue
1989年學術文章
@zh
1989年學術文章
@zh-hant
name
Fractionation parameters for human tissues and tumors.
@en
type
label
Fractionation parameters for human tissues and tumors.
@en
prefLabel
Fractionation parameters for human tissues and tumors.
@en
P2093
P2860
P1476
Fractionation parameters for human tissues and tumors.
@en
P2093
Bentzen SM
Overgaard M
Turesson I
van den Bogaert W
P2860
P304
P356
10.1080/09553008914551931
P577
1989-11-01T00:00:00Z